Skip to main content
. 2022 May 3;13:852414. doi: 10.3389/fphar.2022.852414

TABLE 3.

Preferred drugs during treatment (N = 242).

Drugs TD patients without Comorbidities TD patients with ADHD
Number(n) Ratio (%) Number(n) Ratio (%)
Tiapride 147 60.74 123 50.83
Sulpiride 30 12.40 28 11.57
Haloperidol 62 25.62 61 25.21
Pimozide 5 2.07 6 2.48
Clonidine 79 32.64 79 32.64
Guanfacine 1 0.41 5 2.07
Aripiprazole 40 16.53 52 21.49
Risperidone 15 6.20 31 12.81
Ziprasidone 1 0.41 2 0.83
Olanzapine 6 2.48 7 2.89
Quetiapine 0 0.00 5 2.07
Topiramate 15 6.20 27 11.16
Sodium valproate 30 12.40 44 18.18
Levetiracetam 16 6.61 27 11.16
Aatomoxetine - - 61 25.21
Methylphenidate - - 36 14.88